A retrospective case control study of recombinant factor VIIa in patients with intracranial haemorrhage caused by trauma
Authors:
- 30 January 2011
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 152 (5) , 667-669
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Efficacy of Factor VIIa in Emergency Department Patients With Warfarin Use and Traumatic Intracranial HemorrhageAcademic Emergency Medicine, 2010
- Recombinant Factor VIIa for the Correction of Coagulopathy Before Emergent Craniotomy in Blunt Trauma PatientsJournal of Trauma: Injury, Infection & Critical Care, 2010
- The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial?Journal of Neurosurgery, 2009
- Reversal of Coagulopathy in Critically Ill Patients With Traumatic Brain Injury: Recombinant Factor VIIa is More Cost-Effective Than PlasmaJournal of Trauma: Injury, Infection & Critical Care, 2009
- Recombinant Factor VIIa plus Surgery for Intracerebral HemorrhageCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2008
- Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathyActa Neurochirurgica, 2008
- RECOMBINANT FACTOR VIIA IN TRAUMATIC INTRACEREBRAL HEMORRHAGENeurosurgery, 2008
- Recombinant Factor VIIa: Decreasing Time to Intervention in Coagulopathic Patients With Severe Traumatic Brain InjuryJournal of Trauma: Injury, Infection & Critical Care, 2008
- Coagulopathic Patients With Traumatic Intracranial Bleeding: Defining the Role of Recombinant Factor VIIaJournal of Trauma: Injury, Infection & Critical Care, 2007
- Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hocanalysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trialCritical Care, 2007